Dr. Soliman Abdel Kader Fakeeh (4017.SR)
- Previous Close
46.70 - Open
47.00 - Bid 46.45 x --
- Ask 46.40 x --
- Day's Range
46.00 - 47.15 - 52 Week Range
43.20 - 72.90 - Volume
588,380 - Avg. Volume
552,591 - Market Cap (intraday)
10.66B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
57.02
Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, lasik surgery, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pediatric orthopedic surgery, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery, as well as pain treatment and palliative care services. It also operates AIRS, anesthesia, burn, diagnostics service, emergency medicine, endoscopy, intensive care, NICU, renal dialysis, rhinoplasty, and institute of robotic surgery facilities; establishes and manages pharmacies; and provides analysis and radiology laboratory, healthcare, medical education, and home health care services. In addition, the company engages in the trading of pharmaceutical products, spectacles, and cosmetics; construction and contracting; wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was incorporated in 1978 and is based in Jeddah, the Kingdom of Saudi Arabia.
dsfhjeddah.fakeeh.care--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4017.SR
View MorePerformance Overview: 4017.SR
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4017.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4017.SR
View MoreValuation Measures
Market Cap
10.74B
Enterprise Value
11.04B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
10.30%
Return on Assets (ttm)
4.70%
Return on Equity (ttm)
11.53%
Revenue (ttm)
2.79B
Net Income Avi to Common (ttm)
287.55M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
533.78M
Total Debt/Equity (mrq)
32.47%
Levered Free Cash Flow (ttm)
-129.39M